Log In
BCIQ
Print this Print this
 

DOTA-Zoledronate

  Manage Alerts
Collapse Summary General Information
Company Johannes Gutenberg University Mainz
DescriptionNext-generation theranostic agent for bone-targeted radionuclide therapy and diagnosis of bone metastases.
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBone cancer
Indication DetailsDiagnose bone metastases
Regulatory Designation
PartnerITM Isotope Technologies Munich AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/20/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today